Cc1nc(NC(=O)CSc2ccc(-c3nc4ccccc4[nH]3)cn2)sc1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?